Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Hepatoblastoma

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Hepatoblastoma in 1 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, JA1
Kang, YS1
Lee, SH1
Lee, EH1
Yoo, BH1
Lee, YS1

Other Studies

1 other study available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Hepatoblastoma

ArticleYear
Glibenclamide induces apoptosis through inhibition of cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channels and intracellular Ca(2+) release in HepG2 human hepatoblastoma cells.
    Biochemical and biophysical research communications, 1999, Aug-11, Volume: 261, Issue:3

    Topics: Apoptosis; Caco-2 Cells; Calcium; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Da

1999